      Espa√±ol         Are                  Home                                      Herbs and                                and Vilanterol Oral    of this page:           and Vilanterol Oral  as (ue me'' kli din' ee um) and (vye lan' ter ol )                                 use the sharing features on this page, please enable       is this medication   should this medicine be   uses for this   special precautions should I   special dietary instructions should I   should I do if I forget a   side effects can this medication   should I know about storage and disposal of this   case of   other information should I   names of combination products                            WARNING:                           a large clinical study, more people who used an asthma medication similar to vilanterol experienced severe episodes of asthma that had to be treated in a hospital or caused death than patients who did not use the medication. Use of vilanterol inhalation may increase the risk of serious asthma problems or death in people who have asthma. Umeclidinium and vilanterol inhalation has not been approved by the Food and Drug Administration (FDA) for the treatment of asthma. There is not enough information to tell whether inhaling umeclidinium and vilanterol increases the risk of death in people who have chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and  doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with umeclidinium and vilanterol and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm to obtain the Medication  to your doctor about the risks of using this         is this medication                           combination of umeclidinium and vilanterol is used in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Umeclidinium is in a class of medications called anticholinergics. Vilanterol is in a class of medications called long-acting beta-agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to         should this medicine be                           combination of umeclidinium and vilanterol comes as a powder to inhale by mouth using a special inhaler. It is usually inhaled once a day. Inhale umeclidinium and vilanterol at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use umeclidinium and vilanterol exactly as directed. Do not use more or less of it or use it more often than prescribed by your  not use umeclidinium and vilanterol inhalation during a sudden COPD attack. Your doctor will prescribe a short-acting (rescue) inhaler to use during COPD  and vilanterol inhalation should not be used to treat COPD that is quickly getting worse. Call your doctor or get emergency medical help if your breathing problems worsen, if you have to use your short-acting inhaler to treat attacks of COPD more often, or if your short-acting inhaler does not relieve your  and vilanterol inhalation controls COPD but does not cure it. Continue to use umeclidinium and vilanterol even if you feel well. Do not stop using umeclidinium and vilanterol without talking to your doctor. If you stop using umeclidinium and vilanterol inhalation, your symptoms may get  you use umeclidinium and vilanterol inhalation for the first time, ask your doctor, pharmacist, or respiratory therapist to show you how to use the inhaler. Practice using your inhaler while he or she  use the inhaler, follow these steps:    you will be using a new inhaler for the first time, remove it from the box and the foil tray. Fill in the "Tray opened" and "Discard" blanks on the inhaler label with the date that you opened the tray and the date 6 weeks later when you must replace the  you are ready to inhale your dose, slide the cover down to expose the mouthpiece until it clicks. If you open and close the inhaler without using your dose, you will waste the  counter will count down by 1 each time you open the cover. If the counter does not count down, your inhaler will not provide the medicine. If your inhaler does not count down, call your pharmacist or  the inhaler away from your mouth and breathe out as far as you comfortably can. Do not breathe out into the  the mouthpiece between your lips, and close your lips firmly around it. Take a long, steady, deep breath in through your mouth. Do not breathe in through your nose. Be careful not to block the air vent with your  the inhaler from your mouth, and hold your breath for about 3 to 4 seconds or as long as you comfortably can. Breathe out  may or may not taste or feel the medicine released by the inhaler. Even if you do not, do not inhale another dose. If you are not sure you are getting your dose of umeclidinium and vilanterol, call your doctor or  may clean the mouthpiece with a dry tissue, if needed. Slide the cover up over the mouthpiece as far as it will go to close the          uses for this                           medication may be prescribed for other uses; ask your doctor or pharmacist for more         special precautions should I                           using umeclidinium and   your doctor and pharmacist if you are allergic to umeclidinium, vilanterol, any other medications, milk protein, or any of the ingredients in umeclidinium and vilanterol inhalation. Ask your pharmacist or check the Medication Guide for a list of the  your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: antifungals such as itraconazole (Sporanox), ketoconazole (Nizoral), and voriconazole (Vfend); antihistamines; atropine; beta-blockers such as atenolol (Tenormin), labetalol (Normodyne), metoprolol (Lopressor, Toprol XL), nadolol (Corgard), and propranolol (Inderal); clarithromycin (Biaxin); conivaptan (Vaprisol); diuretics ('water pills'); HIV protease inhibitors such as indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir), and saquinavir (Invirase); other LABAs such as arformoterol (Brovana), formoterol (Foradil, in Symbicort), indacaterol (Arcapta), or salmeterol (in Advair, Serevent); other medications for COPD including aclidinium (Tudorza Pressair), ipratropium (Atrovent HFA), and tiotropium (Spiriva); medications for irritable bowel disease, motion sickness, Parkinson's disease, ulcers, or urinary problems; nefazodone (Serzone); telithromycin (Ketek); and troleandomycin (TAO). Also tell your doctor and pharmacist if you are taking the following medications or have stopped taking them during the past 2 weeks: antidepressants such as amitriptyline (Elavil), amoxapine (Asendin), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Adapin, Sinequan), imipramine (Tofranil), nortriptyline (Aventyl, Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); and monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl), and tranylcypromine (Parnate). Many other medications may also interact with umeclidinium and vilanterol, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side  your doctor if you have or have ever had high blood pressure, irregular heartbeat, seizures, thyroid problems, diabetes, glaucoma (an eye disease), prostate or bladder problems, or heart or liver  your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while using umeclidinium and vilanterol, call your  you are having surgery, including dental surgery, tell the doctor or dentist that you are using umeclidinium and          special dietary instructions should I                           your doctor tells you otherwise, continue your normal         should I do if I forget a                           the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not use more than one dose in a day and do not inhale a double dose to make up for a missed         side effects can this medication                           and vilanterol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:    of a part of your body that you cannot  nervousness  nose, sore  constipation  diarrhea  in your arms or     side effects can be serious. If you experience any of these symptoms, stop using umeclidinium and vilanterol and call your doctor immediately or get emergency medical treatment:    rash  hives  itching  of the face, mouth, or  fast, or irregular   wheezing, or chest tightness that begins after you inhale umeclidinium and  pain, redness, or discomfort; blurred vision; seeing halos or bright colors around lights, sometimes along with nausea and  urinating or urinating in a weak stream or  or painful   and vilanterol may cause other side effects. Call your doctor if you have any unusual problems while using this  you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/Safety/MedWatch or by phone         should I know about storage and disposal of this                           this medication in the foil tray it came in, tightly closed, and out of reach of children. Store it at room temperature and away from sunlight, excess heat and moisture (not in the bathroom). Throw away the inhaler 6 weeks after you remove it from the foil tray or after every blister has been used (when the dose counter reads 0), whichever comes first. Talk to your pharmacist about the proper disposal of your         case of                           case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at  of overdose may include the following:    seizures   of  dizziness  pounding, or irregular  nervousness  headache  of a part of your body that you cannot  cramps or   dry, flushed  nausea   falling asleep or staying    things or hearing voices that do not exist          other information should I                           all appointments with your  not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your  is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of         names of combination                                ¬Æ (containing umeclidinium,      Revised -  06/15/2014      Drugs and        Society of Health-System Pharmacists, Inc.   AHFS ¬Æ Consumer Medication Information. ¬© Copyright, 2015. The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by                                                                    FAQs                                                   email                 to                 us on                                   Disclaimers           Copyright           Privacy           Accessibility                                Connect for                                National Library of         Rockville Pike, Bethesda, MD         Department of Health and Human         Institutes of                             last updated: 20 November                                                      
